[Lung transplantation in chronic obstructive lung diseases].
Lung transplantation (uni- or bilateral) is an accepted treatment option for patients with end-stage chronic obstructive pulmonary disease. Pulmonary function improves significantly and 5-year-actuarial survival is more than 70% at acceptable early mortality rates. Careful evaluation of risks and benefits in necessary because of the known donor-organ shortage and the risks of life-long immunosuppressive treatment. The bronchiolitis obliterans syndrome is still a nonsolved problem in the long-term course after LTx and it can influence late graft function and patient survival.
Demertzis
S
S
Abteilung Thorax- und Herz-Gefässchirurgie, Universitätskliniken des Saarlandes, Homburg/Saar.
Schäfers
H J
HJ
D000328:Adult; D001989:Bronchiolitis Obliterans / Q000209:etiology / Q000401:mortality; D005260:Female; D005858:Germany; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000401:mortality / Q000601:surgery*; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate; D014019:Tissue Donors / Q000600:supply & distribution; D016896:Treatment Outcome
Lungentransplantation bei chronisch obstruktiven Lungenerkrankungen.